1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RCOR3 CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA VANGL2 CTRPv2 pan-cancer AAC 0.2 4e-08
mRNA KCNRG CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA TNFRSF12A CTRPv2 pan-cancer AAC -0.22 4e-08
mRNA FHL2 CTRPv2 pan-cancer AAC -0.19 4e-08
mRNA KCNAB3 CTRPv2 pan-cancer AAC 0.2 5e-08
mRNA EFNB3 CTRPv2 pan-cancer AAC 0.19 5e-08
mRNA ZNF316 CTRPv2 pan-cancer AAC 0.18 5e-08
mRNA HNRNPK CTRPv2 pan-cancer AAC 0.18 5e-08
mRNA ZNF766 CTRPv2 pan-cancer AAC 0.19 5e-08
Download CSV